STATEMENT ON RESTRICTION OF PUBLIC ACCESS
The Chairman may exclude any member of the public from a meeting of the Board of Directors if they are interfering with or preventing the proper conduct of the meeting, or for other special reasons.
The next meeting of the Board of Directors of Royal Papworth Hospital NHS Foundation Trust will be held in public on Thursday 7 December 2023.
Please call Anna Jarvis, Trust Secretary, on 01223 638064 if you plan to attend via Microsoft Teams.
Agendas, past meeting minutes, papers and dates for future meetings can be viewed here.
The Board of Directors is made up of our Chairman, Professor John Wallwork, six other Non-executive Directors and six Executive Directors, including the Chief Executive.
The purpose of the board is to ensure high standards of clinical and corporate governance, monitor performance and ensure effective financial stewardship.
Professor John Wallwork, Chairman
Professor Wallwork was appointed as Chairman in February 2014. He returned to Royal Papworth Hospital as Chairman after spending 30 years at the forefront of transplant surgery and research at the Trust.
Professor Wallwork is Emeritus Professor of Cardiothoracic Surgery. He was a consultant based at Papworth Hospital in Cambridge until his retirement in July 2011.
Before being appointed as a Consultant in 1981, he was Chief Resident at Stanford University Hospital in California for nearly 2 years, where he first became involved in heart and heart-lung transplantation and played a major role in the development of heart-lung transplantation at Papworth Hospital. He performed Europe’s first successful heart-lung transplant in 1984, and in 1986 he performed the world’s first heart-lung and liver transplant with Professor Sir Roy Calne.
During this period he and his colleague, Professor Tim Higenbottam, were first to introduce the use of long-term Prostacycline for Primary Pulmonary Hypertension.
In the mid 1980s he established, with Dr David White, a research bio-tech company (Imutran) to develop transgenic animals for the use of xenotransplantation in an attempt to alleviate the persistent donor organ shortage.
In 1996 he gave evidence on xenotransplantation both to the Kennedy Committee and to the United States Senate Subcommittee on Public Health and Safety.
He succeeded Sir Terence English as Director of the Transplant Service from 1989 to 2006, chaired the UK Transplant Cardiothoracic Advisory Group from 1994 to 2006 and was Medical Director of Papworth Hospital from 1997 to 2002. He was also Director of Research and Development at Papworth Hospital until his retirement.
On 1 October 2002 the University of Cambridge awarded him an honorary Chair in Cardiothoracic Surgery.
In January 2012 Professor Wallwork was recognised in Her Majesty the Queen's New Year's Honours list and was awarded a CBE for services to health.
Mrs Eilish Midlane, Chief Executive Officer
Eilish Midlane became Chief Executive Officer at Royal Papworth Hospital in September 2022, having previously been Chief Operating Officer for five years.
Before joining Royal Papworth in 2017, Eilish was the Divisional Director of Clinical Support Services at East and North Hertfordshire NHS Trust.
Prior to that, she trained and practiced as a biomedical scientist (a sub-group of healthcare scientists) for many years before moving from pathology to general hospital management in 2008.
She holds a wealth of experience spanning strategy, operational leadership and delivery and hospital and clinical services reconfiguration.
Eilish brings with her considerable expertise in patient safety, clinical governance and service improvement planning.
Mr Tim Glenn, Chief Finance Officer and Deputy Chief Executive
Tim joined Royal Papworth Hospital as Chief Finance Officer in April 2020. He was previously with Cambridge University Hospitals NHS Foundation Trust where he was Director of Finance.
Tim is a chartered accountant with 15 years of senior financial leadership experience working across community, acute and specialist NHS organisations as well as in the private sector.
In addition to his role at Royal Papworth Hospital, Tim is a member of the following organisations:
- the Federation of Specialist Hospitals;
- the National Cardiac Benchmarking Collaborative;
- Cambridgeshire and Peterborough Integrated Care System (ICS) Financial Performance & Planning Group (FPPG);
- Cambridge Biomedical Campus Strategy Group
He is also the finance lead for the Cambridgshire and Peterborough ICS' System Delivery & Transformation Working Group and System Clinical Group.
Dr Ian Smith, Medical Director
Dr Ian Smith is the Medical Director of Royal Papworth Hospital. He has particular responsibility for the research direction of the hospital. He has led on the delivery of the Heart and Lung Research Institute a major collaboration with the University of Cambridge and oversaw the establishment of the Papworth Clinical Trials Unit.
Mr Harvey McEnroe, Chief Operating Officer
Harvey joined Royal Papworth Hospital as chief operating officer (COO) in April 2023, having previously held executive and director roles in London and the south east of England.
Before joining Royal Papworth, Harvey was managing director and hospital director at University Hospital Sussex, one of the largest NHS Trusts in England. Before this he was COO and chief strategy officer at Medway NHS Foundation Trust.
During the coronavirus (COVID-19) pandemic, Harvey led his Trust and system response to COVID-19. Latterly he joined the National Vaccine Programme with NHS England as director of integration, leading the planning and deployment for the vaccine booster and children’s vaccines across England.
Harvey has a wealth of experience in operations and operational delivery and has been worked at acute, specialist, system and regional level in senior operational roles, which give him a unique insight into the full range of services provided in today’s NHS, and importantly how to get the best out of them for patients and staff.
Harvey holds a degree in politics and international relations and has focused his continued professional learning in service improvement, change management and healthcare economics in the NHS.
Over his 10 years in senior operations Harvey has led programmes which have improved performance, quality and safety in cancer services, elective care, theatres and post operative care, and emergency care across a number of Trusts, as well as delivering cost reduction and efficiency programmes.
Outside of the NHS Harvey serves as deputy chair of governors for a large federation of schools in south London.
Harvey lives in London with his wife and two young children.
Ms Oonagh Monkhouse, Director of Workforce and Organisational Development
Oonagh joined the Trust in October 2017 having held the same role at Bedford Hospitals NHS Foundation Trust.
Oonagh worked previously at Cambridge University Teaching Hospitals, where she undertook a number of senior human resources roles including Deputy Director of Workforce.
Oonagh is originally from Northern Ireland and worked in a number of NHS organisations in Belfast before moving to Cambridge in 1993.
Mr Andrew Raynes, Director of Digital and Chief Information Officer (CIO)
Andrew joined Royal Papworth Hospital NHS Foundation Trust in 2017 following his role as IT Programme Director at a major London acute. He has over 20 years’ experience working in the health, Local Authority, HMP and private sectors, including overseas. Andrew is a graduate of the Oxford Said Executive Leadership programme, has a Master’s degree in Healthcare Informatics specialising in education and former Chair of the Cambridgeshire and Peterborough Integrated Care System (ICS) Digital Enabling Group.
Andrew leads a multi-award winning digital team at Royal Papworth, is a thought leader, frequent key note presenter and has several publications. He is a member of the National GS1 UK Health Advisory Board and is a CHIME Certified Healthcare Chief Information Officer (CHCIO), a Fellow of the British Computer Society (BCS) and Leading Practitioner in the Federation of Informatics Professionals (FedIP). He was recognised in the CIO UK 100 in 2022, and again in 2023 while also making the global forum CIO 200 in the same year.
Andrew is a non-voting member of the Trust's Board of Directors.
Mrs Maura Screaton, Chief Nurse
Dr Jag Ahluwalia, Non-executive Director
Jag received his undergraduate training in medicine at Cambridge and London, qualifying in 1986. He received his postgraduate training in general practice and then in paediatrics and neonatology in the East of England and in Melbourne.
Jag was appointed as a consultant neonatologist at Cambridge in 1996 where he was director of the neonatal service for many years as well as a practising clinician. Jag’s leadership and management experience includes nearly 10 years as the Executive Medical Director at Cambridge University Hospitals NHS Foundation Trust (CUH).
His wide-ranging portfolio as Medical Director included professional medical governance and leadership for more than 1,400 doctors, executive lead for Research and Development, executive lead for Postgraduate Medical Education, lead for patient safety and Director of Infection Prevention and Control. He was co-Chief Operating Officer for over three years and was executive lead for the award winning Electronic Patient Record system and related IT for over 2 years.
He was appointed Director of Digital at Cambridge in November 2017, overseeing extensive development of the IT programmes and then nominated to be chair of the Cambridgeshire and Peterborough STP digital group.
In addition to his acute hospitals roles, Jag has had many years experience of leading, supporting and managing change and leadership and strategy challenges across the wider NHS. He was an elected senior officer for his clinical professional association, the British Association of Perinatal Medicine for six years, the founding clinical lead for the Norfolk, Suffolk and Cambridgeshire neonatal network, chair of Monitor’s Medical Director Advisory Group, chair of East of England Medical Directors’ Forum and vice-chair of NHS Employers’ Consultant Contract negotiating team.
Jag is also a highly experienced teacher and lecturer with a two-decade track record of delivering lectures and training to heterogeneous as well as specialist audiences, nationally and internationally, across the fields of clinical practice, developing future clinical leaders, managing large-scale change, and implementing clinical IT systems. He has published more than 40 articles, including personal research.
Outside of the immediate NHS, Jag currently sits as a Main Board Trustee of Macmillan Cancer Support, is a member of a number of regional forums focused on the interface between healthcare and technology and is an Honorary Fellow of the Cambridge Judge Business School, focusing on healthcare.
Jag stood down as Director of Digital at CUH in April 2019 to take up a new role as Chief Clinical Officer at the Eastern Academic Health Science Network.
He became a non-executive director at Royal Papworth Hospital in November 2019.
In August 2023 he was appointed as the new Chair of Royal Papworth Hospital, a position he will assume from 1 February 2024, replacing Professor John Wallwork who is stepping down at the end of his latest term following 10 years as Chair.
Michael Blastland, Non-executive Director
Michael Blastland is a writer and broadcaster. For nearly twenty years, he was a BBC current-affairs presenter and producer, devising programmes including More or Less on Radio 4 – about numbers in public argument - of which he was also the first producer (with Andrew Dilnot the original presenter). He can still be heard as an occasional presenter on BBC Radio 4 and the BBC World Service.
He has written four books, including The Tiger that Isn’t, a guide to numbers in the news and politics. His other books are about risk, about his son’s autism, and, most recently, The Hidden Half – How the World Conceals its Secrets, about uncertainty.
He teaches, advises and presents widely, in schools, to business, government and academia. Current health-related roles include advisor to a large meta-analysis of the potential adverse effects of statins, and to the ‘Behaviour Change By Design’ research programme into nudge-type interventions for public health. He is also a board member of the Cambridge-based Winton Centre for Risk and Evidence Communication.
Cynthia Conquest, Non-executive Director
Cynthia is an experienced ex NHS Director of Finance with a wide portfolio of NHS experience covering 39 years.
She has worked in all aspects of financial services and in all types of healthcare settings; large acute teaching hospitals, specialist hospitals, mental health and community services. She has a high level of experience in all financial and healthcare processes with a specialty in financial management and transformation.
Cynthia's diverse experience includes the education sector either through charity work or paid employment as an interim or consultant and the hospice sector through her voluntary work.
Cynthia is currently the Chair of the Audit Committee for a GP Confederation in London and the Chair of the Patients & Family Committee at a Hospice in Suffolk.
She has a master's degree in Business Administration (MBA) from Warwick University and is a Fellow Member of the professional body the Chartered Institute of Public Finance & Accountancy (CIPFA).
Amanda Fadero, Non-executive Director
Amanda enjoyed an extensive, varied and rewarding career in the NHS for over 40 years and the ethos, belief and love of the NHS remains a strong part of who she is and her ongoing contribution to life and work. Her career started in London where she trained and worked as a Paediatric and general nurse, moving into senior nursing leadership and management roles before moving into general management in 1992. Amanda undertook an MBA and held a variety of senior management roles before moving into a strategic joint leadership role across the acute, community and primary care sector in 2005.
Over the next 15 years she held a number of Executive roles working as a commissioner before leading the commissioning system in Sussex as the Chief Executive of NHS Sussex. She then worked as part of the senior team in NHS England as the Area Director for Surrey and Sussex before returning to the provider sector in 2014 as the Deputy Chief Executive and Director of Strategy of a large University Hospitals Trust where she also acted as the Chief Executive. From 2016 Amanda led a large transformation programme to develop population health and integrated care across a number of partners before leading a programme to reform commissioning and develop integrated care across the STP.
As a Trustee and a Non-Executive Director, Amanda possess valuable experience in leading transformation, managing complexity, using problem solving and conflict resolution to progress and manage change. She values relationships and partnerships which she believes to be essential, supported by strong governance, rigorous assurance processes and using appreciative enquiry, to secure safe, effective and efficient services for the members of the public who require them.
Diane Leacock, Associate Non-executive Director
Diane is a qualified accountant with extensive business experience. She has held Finance Director roles at various commercial organisations including the information and publishing group Informa UK, insurance broker Willis Towers Watson and the regional law firm, Ellisons where she has streamlined, grown and transformed various business units. Currently, Diane works as an independent finance consultant, supporting businesses experiencing challenging situations.
Diane has a keen interest in healthcare and has served as a non-executive director within the NHS, most recently at the East Suffolk and North Essex NHS Foundation Trust and at the North East Essex Primary Care Trust (now NHS North East Essex Clinical Commissioning Group). She also sits on the Board of Trustees at the East of England’s award-winning contemporary visual arts gallery, Firstsite.
An Economics graduate of the University of Waterloo (Canada), Diane holds a Masters in Business Administration from Henley Business School and is a Fellow of the Association of Chartered Certified Accountants.
Gavin Robert, Non-executive Director
Gavin has many years’ experience as a private practice lawyer specializing in competition law. He is currently a senior consultant with boutique competition law firm Euclid Law, and teaches competition law at Cambridge University as part of a Masters programme. Gavin was previously a Panel Member of the UK Competition & Markets Authority, where he decided complex merger, market and antitrust cases, for five years until March 2018. Before that, Gavin was a partner for 14 years with the international law firm Linklaters, advising senior executives and the boards of leading global companies and financial institutions on competition compliance and managing risk.
Gavin has an enduring interest in healthcare. He has advised global healthcare companies throughout his career, and his decisions at the UK Competition & Markets Authority included the merger of NHS Foundation Trusts.
Gavin is also Vice Chair of REAch2, the largest primary-only multi-academy trust in the country. It is a growing charitable organisation currently supporting around 60 primary academies across England.
Professor Ian Wilkinson, Non-executive Director
Ian Wilkinson is a Clinical Pharmacologist and Professor of Therapeutics in the University of Cambridge.
He directs the Cambridge Clinical Trials Unit, and office of Translational Research, and leads the division of Experimental Medicine and Immunotherapeutics at the University of Cambridge. His main research interests are clinical/experimental studies designed to understand the mechanisms causing hypertension and cardiovascular disease, and to develop new treatments.
He is lead investigator on the MRC/BHF-funded AIMHY-INFORM trial, which will determine the most effective antihypertensive treatment for different ethnic groups in the UK, and a number of early phase trials run in collaboration with Industry partners.
Professor Wilkinson also leads the Cambridge Experimental Medicine Training Initiative – which aims to create the next generation of clinical researchers to develop the medicines of the future.